Cambridge, United Kingdom

Magda Anastassova Dineva

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 3.2

ph-index = 3

Forward Citations = 34(Granted Patents)


Location History:

  • Cambridgeshire, GB (2019)
  • Cambridge, GB (2007 - 2022)

Company Filing History:


Years Active: 2007-2022

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Magda Anastassova Dineva: Innovator in Nucleic Acid Amplification

Introduction

Magda Anastassova Dineva is a prominent inventor based in Cambridge, GB. She has made significant contributions to the field of nucleic acid amplification, holding a total of 12 patents. Her work focuses on developing methods that enhance the efficiency and accessibility of nucleic acid testing.

Latest Patents

Dineva's latest patents include innovative methods for amplifying a target nucleic acid through self-sustained amplification techniques. These methods are particularly designed to be executed without the need for specialized laboratory facilities or instruments. Additionally, her patents describe compositions, lyophilized formulations, and kits that facilitate the implementation of these methods.

Career Highlights

Throughout her career, Dineva has worked with notable companies such as Diagnostics for the Real World, Ltd. and Cambridge Enterprise Limited. Her expertise in nucleic acid amplification has positioned her as a key figure in the development of accessible testing methods.

Collaborations

Dineva has collaborated with esteemed colleagues, including Helen Lee and Hsiang Yun Hu, further enhancing her contributions to the field.

Conclusion

Magda Anastassova Dineva's innovative work in nucleic acid amplification has paved the way for more accessible testing methods, demonstrating her significant impact on the field. Her patents and collaborations reflect her dedication to advancing scientific research and technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…